Novo Nordisk
E455777
Novo Nordisk is a global healthcare company based in Denmark, best known as a leading producer of insulin and other diabetes care treatments.
All labels observed (5)
| Label | Occurrences |
|---|---|
| Novo Nordisk canonical | 5 |
| Novo Nordisk A/S | 1 |
| Novo Nordisk Inc. | 1 |
| Novo Nordisk Kalundborg | 1 |
| Novo Nordisk global corporate structure | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4649558 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Novo Nordisk Context triple: [Nasdaq Copenhagen, listedCompany, Novo Nordisk]
-
A.
Sanofi
Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
-
B.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
C.
Eli Lilly and Company
Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
-
D.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
E.
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, branded generic medicines, and nutritional products.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Novo Nordisk Target entity description: Novo Nordisk is a global healthcare company based in Denmark, best known as a leading producer of insulin and other diabetes care treatments.
-
A.
Sanofi
Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
-
B.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
C.
Eli Lilly and Company
Eli Lilly and Company is a major American pharmaceutical corporation known for developing and manufacturing a wide range of prescription medicines, including treatments for diabetes, cancer, and mental health disorders.
-
D.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
E.
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, branded generic medicines, and nutritional products.
- F. None of above. chosen
Statements (50)
| Predicate | Object |
|---|---|
| instanceOf |
Biotechnology company
ⓘ
Pharmaceutical company ⓘ Public company ⓘ |
| country | Denmark ⓘ |
| focusesOn |
Chronic disease management
ⓘ
Metabolic disorders ⓘ |
| formedByMergerOf |
Nordisk Gentofte
ⓘ
Novo Industri ⓘ |
| foundedBy |
August Krogh
ⓘ
Hans Christian Hagedorn ⓘ Marie Krogh ⓘ |
| hasDivision |
Diabetes and Obesity Care
ⓘ
Rare Disease ⓘ |
| hasParentOrganization | Novo Holdings ⓘ |
| hasSubsidiary |
Novo Nordisk Inc.
ⓘ
linked to:
Novo Nordisk
|
| headquartersLocation | Bagsværd, Denmark ⓘ |
| inception | 1923 ⓘ |
| industry |
Biotechnology industry
ⓘ
Healthcare ⓘ Pharmaceutical industry ⓘ |
| legalForm | Aktieselskab ⓘ |
| listedOn | New York Stock Exchange ⓘ |
| majorProduct |
Levemir
ⓘ
NovoRapid ⓘ Ozempic ⓘ Rybelsus ⓘ Saxenda ⓘ Tresiba ⓘ Victoza ⓘ
linked to:
Trulicity
Wegovy ⓘ |
| memberOf |
EFPIA
ⓘ
International Diabetes Federation corporate partners ⓘ |
| numberOfEmployees | over 50,000 ⓘ |
| operatesIn |
Africa
ⓘ
Asia ⓘ Europe ⓘ Latin America ⓘ North America ⓘ |
| researchFocus |
GLP-1 receptor agonists
ⓘ
linked to:
Trulicity
Insulin analogues ⓘ Obesity pharmacotherapy ⓘ |
| specializesIn |
Diabetes care
ⓘ
Growth hormone therapy ⓘ Haemophilia treatment ⓘ Insulin production ⓘ Obesity care ⓘ |
| stockExchange | Nasdaq Copenhagen ⓘ |
| tickerSymbol |
NOVO-B
ⓘ
NVO ⓘ |
| website | https://www.novonordisk.com ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Novo Nordisk Description of subject: Novo Nordisk is a global healthcare company based in Denmark, best known as a leading producer of insulin and other diabetes care treatments.
Referenced by (9)
Full triples — surface form annotated when it differs from this entity's canonical label.
linked to: Novo Nordisk
linked to: Novo Nordisk
linked to: Novo Nordisk
linked to: Novo Nordisk